Cumberland Pharmaceuticals (CPIX) Receivables - Net (2016 - 2025)
Cumberland Pharmaceuticals' Receivables - Net history spans 16 years, with the latest figure at $16.9 million for Q4 2025.
- For Q4 2025, Receivables - Net rose 44.81% year-over-year to $16.9 million; the TTM value through Dec 2025 reached $16.9 million, up 44.81%, while the annual FY2025 figure was $16.9 million, 44.81% up from the prior year.
- Receivables - Net for Q4 2025 was $16.9 million at Cumberland Pharmaceuticals, up from $10.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $16.9 million in Q4 2025 and bottomed at $6.9 million in Q4 2021.
- The 5-year median for Receivables - Net is $11.7 million (2024), against an average of $12.0 million.
- The largest YoY upside for Receivables - Net was 110.92% in 2021 against a maximum downside of 44.44% in 2021.
- A 5-year view of Receivables - Net shows it stood at $6.9 million in 2021, then skyrocketed by 91.41% to $13.2 million in 2022, then decreased by 4.13% to $12.6 million in 2023, then decreased by 7.28% to $11.7 million in 2024, then skyrocketed by 44.81% to $16.9 million in 2025.
- Per Business Quant, the three most recent readings for CPIX's Receivables - Net are $16.9 million (Q4 2025), $10.4 million (Q3 2025), and $10.3 million (Q2 2025).